Testosterone level should be monitored Anadrol baseline and at regular intervals during treatment. Clinicians should adjust the dosage individually to ensure maintenance of eugonadal testosterone levels. Physicians should consider monitoring patients receiving Andriol Testocaps before the start of treatment, at quarterly intervals for the first 12 months and yearly thereafter for the following parameters: Digital rectal examination DRE of the prostate and PSA to exclude benign prostate hyperplasia or a Oxymetholone tablets prostate cancer see Section 4. Haematocrit and haemoglobin to exclude polycythaemia. Conditions that need supervision.